278. The Evidence: Intermittent Fasting Effects on Cardiometabolic Disease and Cancer

FNCE Recorded Sessions from 2017

This session will present evidence supporting the benefits of intermittent fasting related to obesity, obesity-related conditions and chronic diseases, including cancer and diabetes.

  • SKU FNCE17278
Member Price
$32.00
Nonmember Price
$37.00

This product is free for those who attended FNCE® 2017.

RDNs have long been advising clients to eat small frequent meals for optimal health. However, according to recent evidence regarding intermittent fasting, RDNs should consider possible health benefits of modifying their message to clients. Intermittent fasting, the periodic abstinence of food, may be effective for preventing and treating many diseases. This session will present evidence supporting the benefits of intermittent fasting related to obesity, obesity-related conditions and chronic diseases, including cancer and diabetes. Further, this session will examine the proposed mechanisms of action and feasibility and practicality of implementing intermittent fasting in different patient populations.

CPEU: 1.5
CPE Level: 2
Learning Codes: 5150, 4040, 5370

Learning Objectives

  • Describe and define intermittent fasting and the effects of intermittent fasting on cancer, obesity, diabetes, and other chronic diseases.
  • Identify possible mechanisms of action for the role of intermittent feeding in preventing and treating chronic disease states.
  • Detail the evidence of intermittent fasting in the prevention and treatment of cancer and determine the feasibility of implementing intermittent fasting with cancer patients.

Speaker

  • Dorothy Sears, PhD
  • Mahshid Shelehchi, MS, RDN

Moderator and Program Planner

  • Heather Bell-Temin, MS, RD, CSO

Planned with the Oncology Nutrition Dietetic Practice Group

  • SKU FNCE17278